20285-Myelomas-NA-150

Myelomas

A phase II trial of daratumumab, lenalidomide and dexamethasone (DRd) in combination with selinexor for patients with newly diagnosed multiple myeloma (USOR 20285)

  • Details

ClinicalTrials.gov ID: NCT04782687
Diagnosis Type: NA
USOR Number:

  • Address

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

Search by practice name, trial titles, indicators and specific disease types.